✦ LIBER ✦

An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients

✍ Scribed by Agostino Cortelezzi; Giuseppe Gritti; Luca Laurenti; Antonio Cuneo; Stefania Ciolli; Nicola Di Renzo; Pellegrino Musto; Francesca R. Mauro; Nicola Cascavilla; Lorenzo Falchi; Francesco Zallio; Vincenzo Callea; Francesco Maura; Sara Martinelli; Alfonso Piciocchi; Gianluigi Reda; Robin Foà; on behalf of the GIMEMA Chronic Lymphoproliferative Disorders Working Party

Book ID: 108677517
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 173 KB
Volume: 156
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2011.08965.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Routine clinical use of alemtuzumab in p

Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia : A nation-wide retrospective study in Austria

✍ Michael Fiegl; Andreas Falkner; Georg Hopfinger; Stefan Brugger; August Zabernig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 1 views

## Abstract ## BACKGROUND. In previous studies, alemtuzumab demonstrated considerable activity in patients with previously treated B‐cell chronic lymphocytic leukemia (CLL), including fludarabine‐refractory disease. In this retrospective study, the authors evaluated the benefit of alemtuzumab mono